As outlined in the published final package of, ‘Community Pharmacy in 2016/17 and beyond’1, the Government is committed to pursuing a number of reimbursement reforms and taking steps to improve the prescription ordering journey to maximise patient choice and convenience.
The reimbursement reforms include:
- changes to Category M for certain generic medicines to better reflect their market price;
- changes to the margin survey to account for multiple suppliers for Non Part VIII products and Category C products;
- ‘splitting the discount’- to reflect that in general generic medicines have increased margin over brands; and
- changes to the way Category A prices are set.
The Government has also recently committed to reforming reimbursement arrangements for specials.